soliris drug

Soliris (Eculizumab Injection) Dosage, and Side Effects

Background: Soliris (Eculizumab Injection) is a medicine launched for the treatment of patients with paroxysmal nocturnal haemoglobinuria (PNH), generalised myasthaenia gravis (GMG), atypical haemolytic uraemic syndrome (aHUS), and neuromyelitis optica spectrum disorder (NMOSD). The medication is developed and manufactured by the US based pharmaceutical company Alexion Pharmaceuticals, a subsidiary of AstraZeneca. It was given orphan […]